Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder

MLA

Uehleke, B., et al. “Phase II Trial on the Effects of Silexan in Patients with Neurasthenia, Post-Traumatic Stress Disorder or Somatization Disorder.” Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, vol. 19, no. 8–9, June 2012, p. 665. EBSCOhost, https://doi.org/10.1016/j.phymed.2012.02.020.

APA

Uehleke, B., Schaper, S., Dienel, A., Schlaefke, S., & Stange, R. (2012). Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder. Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, 19(8–9), 665. https://doi.org/10.1016/j.phymed.2012.02.020

Chicago

Uehleke, B., S Schaper, A. Dienel, S. Schlaefke, and R. Stange. 2012. “Phase II Trial on the Effects of Silexan in Patients with Neurasthenia, Post-Traumatic Stress Disorder or Somatization Disorder.” Phytomedicine: International Journal of Phytotherapy & Phytopharmacology 19 (8–9): 665. doi:10.1016/j.phymed.2012.02.020.